The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Molecular Analyses.
- Who it may be relevant to
- Registry conditions: Head and Neck Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United Kingdom
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The RESCUE study is a combined retrospective and prospective multicentre cohort study investigating the survival and functional outcomes in patients undergoing salvage surgery for recurrent, residual, and new primary head and neck squamous cell carcinoma (SCC). Additionally, the RESCUE study will contain an exploratory molecular analysis of consenting patients to assess the relationship between cancer genomics, previous radiotherapy, and recurrence in head and neck cancer.
Detailed description
The RESCUE study is a combined retrospective and prospective multicentre cohort study investigating the survival and functional outcomes in patients undergoing salvage surgery for recurrent, residual, and new primary head and neck squamous cell carcinoma (SCC).
Additionally, the RESCUE study will contain an exploratory molecular analysis of consenting patients to assess the relationship between cancer genomics, previous radiotherapy, and recurrence in head and neck cancer.
The aim of this study is to determine the survival, functional and quality of life outcomes of patients undergoing all salvage surgery for recurrent, residual and new primary head and neck SCC, and to establish the genetic architecture and clonal evolution H\&N SCC after previous treatment for radiotherapy cancer.
Interventions
- Genetic Molecular Analyses
Nucleic acid extraction, protein analysis. Tumour tissue, blood and saliva samples collected.
Primary outcome measures
- Ascertain the 2-year disease-free survival post salvage surgery [Time frame: Study duration is 3 years to include 1 year recruitment period. Active follow-up for patients is up to 2 years.]
Secondary outcome measures (12)
- Define the 2- and 5-year overall and disease specific survival in retrospectively identified patients [Time frame: Study duration is 3 years to include 1 year recruitment period. Active follow-up for prospective patients is up to 2 years. Follow-up for retrospective patients is up to 5 years.]
- Define the 2 year overall and disease specific survival in prospectively identified patients [Time frame: Study duration is 3 years to include 1 year recruitment period. Active follow-up for patients is up to 2 years.]
- Report on gross functional outcomes by documenting rates of gastrostomy and tracheostomy dependence at 1-year post-salvage surgery. [Time frame: Study duration is 3 years with up to 2 years follow-up in prospective and up to 5 years follow-up in retrospective patients. Functional outcomes will be measured from the date of surgery.]
- For the prospective cohort assess the overall quality-of-life outcomes pre-operatively and at 6- and 12-months post-surgery using validated questionnaires. [Time frame: University of Washing Quality of life questionnaire distributed pre-operatively, 6 months and 12 months.]
- For the prospective cohort assess the swallow-related quality-of-life outcomes at pre-operatively and at 6- and 12-months post-surgery using validated questionnaires. [Time frame: MD Anderson Dysphagia Inventory distributed pre-operatively, 6 months and 12 months.]
- Estimate the rates of close and involved surgical margins across all surgical salvage procedures [Time frame: Through study completion, expected duration of 3 years]
- Determine the impact of close and involved margins on overall survival outcomes [Time frame: Through study completion, expected duration of 3 years]
- Determine the impact of close and involved margins on disease-free survival outcomes [Time frame: Through study completion, expected duration of 3 years]
- Determine the impact of close and involved margins on disease-specific survival outcomes [Time frame: Through study completion, expected duration of 3 years]
- Establish the rates of super-selective, selective and modified/ radical salvage neck dissection in clinically N0 and N+ necks [Time frame: Through study completion, expected duration of 3 years]
- Ascertain how the extent of salvage neck dissection influences overall survival outcomes. [Time frame: Through study completion, expected duration of 3 years]
- Ascertain how the extent of salvage neck dissection influences disease-free survival outcomes. [Time frame: Through study completion, expected duration of 3 years]
Eligibility criteria
Inclusion criteria
- Aged over 18
- Previous H\&N SCC treated with radiotherapy with or without chemotherapy
- Local or regionally recurrent, residual, or new primary SCC of the oropharynx, oral cavity, larynx, and hypopharynx
- Ability to give informed consent for biological sample collection (molecular analysis study only)
Exclusion criteria
- Nasopharyngeal and cutaneous SCC of the H\&N
- Thyroid, salivary gland, and non-squamous cell H\&N cancers
- Presence of distant metastasis (M1) or surgically inoperable T4b tumours
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United Kingdom · 9 centers
- University Hospitals Derby and Burton — Derby
- NHS Lothian — Edinburgh
- Western General, Greater Glasgow and Clyde — Glasgow
- Aintree Hospital — Liverpool
- Head and Neck Unit, Royal Marsden Hospital — London
- Northwick Park — London
- Oxford University Hospital NHS Foundation Trust — Oxford
- Poole Hospital, University Hospitals Dorset — Poole
- … and 1 more center
Identifiers
NCT: NCT05808920 · CCR 5752